To Attain Diversity in Clinical Trial Enrollment, It Takes a Village
Coverage from the session, "Bringing Health Equity to Clinical Trials at Every Step," at Patient-Centered Oncology Care 2023.
When Choosing Between Bispecifics and CAR T, the Best Therapy May Be What Is Accessible
Coverage from the session, "Which Comes First? Bispecifics, CAR T-Cell Therapy, and Cost Consideration in Sequencing,” at Patient-Centered Oncology Care 2023.
Tennessee Oncology’s Brandes Sees Progress in Biomarker Use in NSCLC, but “There’s Work to Be Done”
Coverage of Tennessee Oncology's Johann Brandes, MD, on "Precision Medicine in NSCLC."
"Interventions Are Needed at Every Step"
MD Anderson's Ryan Huey, MD, offers a survey of research on a holistic approach to addressing financial toxicity during Patient Centered Oncology Care 2023.
Mitigating Financial Toxicity in Cancer Care Requires Policy Reform, Rethinking Benefit Design
From the panel discussion, "The Burden They Carry," a discussion of the impact of financial toxicity over the duration of the cancer journey.
How Can Oncology Clinical Pathways Contribute to Burnout? Lucy Langer, MD, MSHS, Explains
From an interview conducted during Patient-Centered Oncology Care 2023.
Innovation in Value-Based Care Requires More Data, Patient-Centered Thinking
Experts discussed the Enhancing Oncology Model and themes in the movement toward value-based care in oncology during Patient-Centered Oncology Care 2023.
Merril Hoge Brings the Patient Perspective to PCOC 2023
The former NFL running back shared his story of overcoming cancer and encouraged an audience of oncologists, pharmacists, payers, and policy leaders to continue pushing to advance cancer treatment.
Edward R. Arrowsmith, MD, MPH: Trust and Compromise Are Essential in Building Oncology Clinical Care Pathways
Panelists Explore the Role of Oncology Clinical Pathways in a Changing Landscape
Coverage from the panel discussion, "Can Clinical Pathways Have Burnout, Too?" at Patient-Centered Oncology Care 2023.
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, Discusses Chemotherapy Shortage Challenges and Solutions
Genomic Testing Is Worth the Wait When Balanced Against Cost of the Wrong Therapy
Coverage from the discussion, "Cancer Genomics: The Gateway to Access and Health Equity” on the first day of Patient-Centered Oncology Care 2023.
Samyukta Mullangi, MD, MBA, Discusses Leveraging Technology Intelligently in Oncology Care
In Cancer Care, Building Trust Requires Understanding, Meeting Patients Where They Are
PBMs: When Competition Does Not Benefit Consumers
Coverage from "Navigating the PBM Landscape: How a Heath Care Economist Sees It," at Patient-Centered Oncology Care 2023.
Texas Oncology’s Hudson Shares How ePROs Helped Reduce Cost of Care
Kathryn E. Hudson, MD, of Texas Oncology was a featured speaker at Patient-Centered Oncology Care 2023.
